“I think it’s important for the American people to understand we’re not going to drill our way out of this problem. It’s also important to recognize if you start drilling now you won’t see a drop of oil for ten years, which means it’s not going to have a significant impact on short-term prices.” - U.S.

Enzon Pharmaceuticals Inc. said Monday it could possibly sell its specialty pharmaceuticals unit as it moves forward with a spinoff of its biotechnology division.

BRIDGEWATER, N.J.—-Enzon Pharmaceuticals, Inc. announced today that it is exploring strategic alternatives for its specialty pharmaceuticals business. These alternatives include, among other things, selling the entire specialty pharmaceuticals business, or selling one or more of Enzon’s marketed products, Oncaspar®, DepoCyt®, Abelcet® and Adagen®, and its Indianapolis, Indiana manufacturing …

Xoft, Inc., developer of Electronic Brachytherapy , a proprietary cancer treatment platform, announced today that the company has closed its Series E preferred stock financing, raising a total of $25 million in additional funding.

Verizon quarterly profit gains, led by wireless NEW YORK - Verizon Communications Inc posted a higher-than-expected quarterly profit on Monday on strong wireless sales and improved margins, offsetting a fall in landline users. Executives said on a conference call that the No. 2 U.S. phone company did not expect a significant impact from the weaker economy, though demand from …